Hydrochlorothiazide Tablet
Product Images NDC 76282-154

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 76282-154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is A Picture Of The Label Hydrochlorothiazide Tablets, Usp, 25 mg, 30 Count. (Hydrochlorothiazide 25 mg 90 Tab)

This is a description of Hydrochlorothiazide Tablets USP 25 mg manufactured by Ascent Pharmaceutical, Inc. and distributed by Exelan Pharmaceuticals, Inc. It is a prescription drug and should be stored at 20-25°C (68-77°F), in a well-closed container as defined in the USP. The tablets come in a package of 90, and the usual dosage should be determined by a healthcare provider.*

FDA Label Image

This Is A Picture Of The Label Hydrochlorothiazide Tablets, Usp, 25 mg, 30 Count. (Hydrochlorothiazide 50mg 90tab)

FDA Label Image

Hydrochlorothiazide-structure (Hydrochlorothiazide Str)

The text is providing chemical formula and molecular weight for a compound. Its name or other properties are not available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.